Is there still a shortage of IV fluids?
As of September 2026, the broad U.S. saline shortage associated with Hurricane Helene has been resolved, but individual IV solutions, concentrations, container sizes, or suppliers may still experience constraints. Current FDA and ASHP shortage databases should be checked for product-specific status.
Answer
The nationwide U.S. shortage of standard intravenous and injectable saline caused by Hurricane Helene and the disruption of Baxter’s North Cove facility was declared resolved in August 2025. Baxter had restored inventory, while other manufacturers increased production and temporary imports supported the recovery. However, the end of that broad shortage does not mean every IV fluid is continuously available in every presentation. The FDA continued monitoring other IV solutions that remained constrained.
IV-fluid availability is product-specific. Shortages can affect a particular electrolyte concentration, bag size, container material, premixed drug, pediatric presentation, or manufacturing source while standard saline remains available. For example, concentrated sodium chloride injections and specialized solutions may have different supply conditions from routine 0.9% sodium chloride bags.
Hospitals and distributors should verify current status through the FDA Drug Shortages database and the ASHP Current Drug Shortages resource. Manufacturer allocation notices and wholesaler inventories provide additional operational information.
Long-term vulnerability remains because sterile IV fluids require capital-intensive production, terminal sterilization, specialized packaging, and high-volume distribution. Supply continuity planning may therefore include qualified secondary suppliers, clinically approved alternatives, inventory thresholds, conservation protocols, and visibility into production-site concentration. Shortage status should always be stated by country and date rather than treated as a permanent global condition.
Trust Our Expert Answers?